Medical Packaging Market Forecasts to 2028 – Global Analysis By Drug Delivery Mode (Inhalable, Oral & Injectable, Dermal/Topical), Type (Paper & Paperboard, Non Woven Fabric, Plastics & Polymers, Composites, Glass, Metal), Product Type (Secondary, Primary

Medical Packaging Market Forecasts to 2028 – Global Analysis By Drug Delivery Mode (Inhalable, Oral & Injectable, Dermal/Topical), Type (Paper & Paperboard, Non Woven Fabric, Plastics & Polymers, Composites, Glass, Metal), Product Type (Secondary, Primary, Tertiary, Other Product Types), Application (Plastic Industries, Chemicals, Pharmaceuticals, Diagnostics, Other Applications) and By Geography

According tStratistics MRC, the Global Medical Packaging Market is accounted for $1.55 billion in 2022 and is expected treach $2.66 billion by 2028 growing at a CAGR of 9.4% during the forecast period. Medical packaging is an important step because it's essential tpreserving the quality of the medicine within. Pharmaceutical packaging protects the product in line with its composition because some formulations require isolation against air, water, environmental pollutants, light, and other chemicals. Significant advancements in medicine, such as the commercialization of biologics and biosimilars as well as the use of nutraceuticals and synbiotics, have led ta considerable expansion of the pharmaceutical market, which has had a favourable effect on the medical packaging sector.

According tstudies, the Indian pharmaceutical industry supplies, about 50% of the global demand for various vaccines, 40% of the U.S. market for generic drugs and 25% of the UK market for all medicines. According tdata from the European Federation of Pharmaceutical Industries and Associations (EFPIA), North America sold over 40% of all pharmaceutical products globally in 2020. Numerous businesses that specialize in pharmaceutical packaging serve well-known pharmaceutical firms.

Market Dynamics:

Driver:

Increased worldwide consumption of drugs

The increased use of medications on a global scale is a significant factor in market expansion. Due tthe rising frequency and severity of chronic illnesses, busy lifestyles, and population ageing, drug use is on the rise globally. Traditional approaches tmedication production have been replaced by technologically advanced ones, which has completely changed the industry and made it one that is distinguished by the employment of sophisticated machinery, expensive investments, and technology. Drug producers worldwide are now able tmeet rising customer demand for medications in various forms while upholding quality standards thanks ttechnological advancements, modifications tthe manufacturing process, and improved efficiency. These developments in the pharmaceutical sector will boost demand for cutting-edge medications and drive the market.

Restraint:

Lack of knowledge and the shortage of qualified staff

Financial limitations and outdated equipment are a drag on the growing medical business in developing countries. Further barriers tthe expansion of the pharmaceutical sector include a knowledge gap and a staffing deficit. The biggest barrier tobtaining health is a lack of knowledge of better medical practises, which has an impact on the medical packaging business. These issues collectively restrict the size of the medical packaging market in emerging economies such as India, Brazil, South Africa, and others. The market will be strengthened during the predicted period, nonetheless, by stricter enforcement of the laws and better government policies.

Opportunity:

Rising Prevalence of Chronic Diseases

The rising frequency of chronic diseases and the ageing population's combined effects on social behaviour are major drivers of market expansion. Many pharmaceuticals or medications are readily accessible in the marketplace for the treatment of medical conditions since both the government and the general public desire healthy lifestyles. Each medicine must be packaged tguard against contamination and harm from the outside. The governments of many areas have improved research and development in response tthe sharp increase in chronic diseases in order tproduce new, efficient medications for the chronic disease treatment, which supports the expansion of the medical packaging market.

Threat:

Harmful Polymer Packaging

Polymer is currently primarily used in pharmaceutical packaging despite its high production, cost-effectiveness, and durability. Nevertheless, polymer harms environmental quality, takes a very long time tbiodegrade, and increases pollutants. Polymers can occasionally react with products, resulting in product contamination that is harmful thuman health. As the production of polymer takes place in facilities where toxic waste and excessive carbon dioxide are released intthe environment, it is essential that polymer makers abide by all applicable rules and regulations.

Covid-19 Impact

COVID-19 has a variety of effects on the packaging business but still there continues tbe a high need for medical packaging,. Tenhance immunity and prevent viral infection during this pandemic, an enormous amount of medications were needed, which aided in the market's expansion. On the other hand, the lack of raw resources, storage space, and labour caused by the global shutdown has made it extremely difficult for manufacturers tstrike a balance between supply and demand. Packaging producers are being forced tconcentrate on diverse products, regional diversity, and stringent lockout laws in many countries.

The Plastics & Polymers segment is expected tbe the largest during the forecast period

The Plastics & Polymers segment is estimated thave a lucrative growth. Polypropylene packaging for medications is a practical and affordable option. Blister packs, strip packages, sachets, pre-fillable syringes and nasal spray, pouches for parenteral solutions, or bottles are all packaged with plastics. Medical packaging needs tbe made of materials that are easy thandle, have low water vapour permeability, and are chemically inert. Additionally, because the packing materials come intcontact with drugs and biological agents directly, they are subject tstringent requirements set forth by regulatory organisations. These conditions are met by plastics and polymers, which is why they are frequently employed in medical packaging.

The pharmaceutical segment is expected thave the highest CAGR during the forecast period

The pharmaceutical segment is anticipated twitness the fastest CAGR growth during the forecast period, due tthe arrival of novel technologies with affordable and effective manufacturing processes, in addition tincreasing high-value investments. Manufacturer need for packaging materials is rising as a result of the increasing number of medications being approved by regulatory authorities and the increased production of such drugs. Increasing mergers and acquisitions in the pharmaceutical sector are alsone of the key drivers of market expansion.

Region with highest share:

Asia Pacific is projected thold the largest market share during the forecast period owing tthe expansion of the healthcare system, contract manufacturing, government efforts, the increasing population, as well as an increase in the sales of over-the-counter (OTC) medications. Hospitals as well as other medical facilities have increased in number as a result of the rapid economic growth in nations like China, India, Japan, and South Korea. China offers domestic makers of medical products generous tax policies.

Region with highest CAGR:

North America is projected thave the highest CAGR over the forecast period, owing tincrease in the need for dependable, high-quality packaging solutions as more businesses have attempted tenhance their product offers by supplying better packaging materials. As well, the existence of numerous pharma companies is probably going tgive the market a boost. The medical packaging market in North America will expand as a result of these firms' active efforts tcreate new drugs and their advancements in technologies like biologics and nanomedicines.

Key players in the market

Some of the key players profiled in the Medical Packaging Market include Mitsubishi Chemical Holdings Corporation, Amcor Limited, 3M Company, DuPont, SonocProducts Company, WestRock Company, NiprCompany, Sealed Air Corporation, Mondi PLC, Berry Global, Inc.
NiprCorporation and West Pharmaceutical Services, Inc.

Key Developments:

In April 2021, Amcor Plc (Switzerland) launched customer trials for a new mono-material, recyclable polyethylene blister pack—AmSky. This brand eliminates the use of polyvinyl chloride, making recycling possible.

Drug Delivery Modes Covered:
• Inhalable
• Oral & Injectable
• Dermal/Topical

Types Covered:
• Paper & Paperboard
• Non Woven Fabric
• Plastics & Polymers
• Composites
• Glass
• Metal

Product Types Covered:
• Secondary
• Primary
• Tertiary
• Other Product Types

Applications Covered:
• Plastic Industries
• Chemicals
• Pharmaceuticals
• Diagnostics
• Other Applications

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements